HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Products In Brief: Bee Bald Adds To Line; AXE For Women; More

This article was originally published in The Rose Sheet

Executive Summary

Bee Bald Shave and Bee Bald Scrub debut from brand focused on the “follically challenged,” while AXE caters to its female fans with new shower gels for women. More new products in brief.

You may also be interested in...



The Evolution Of Unilever's AXE: From Babe Magnet To Personal Guru

AXE is taking a "bold new direction" with its marketing, encouraging men to celebrate their uniqueness and look to AXE for its product innovations and grooming advice, rather than the brand's irresistible aphrodisiac powers promoted in the past. The Unilever unit is targeting new "Find Your Magic" messaging to consumers in the US and abroad with cross-channel advertising, including a video created by 72andSunny Amsterdam.

New York Elements Show Highlights Design Standouts Across Categories

Elements Showcase’s New York installation brought together fragrance, cosmetics, nail-care and men’s grooming brands, among others, to shine a light on notable craftsmanship and design.

In Brief

SkinMedica is acquired by BOTOX and Latisse maker Allergan for $350 million. NAD says BIC USA can support claims that its razors feature “flexible blades” following a challenge by Schick marketer Energizer Personal Care.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018672

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel